Moody's saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 66 to 73.
How To Invest In Stocks In Both Bull And Bear Markets
IBD's proprietary rating measures share price movement with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the best stocks tend to have an RS Rating of over 80 as they launch their biggest climbs. See if Moody's can continue to rebound and hit that benchmark.
Moody's is now considered extended and out of buy range after clearing a 480.86 buy point in a first-stage double bottom. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The company showed 9% EPS growth in its most recent report, while sales growth came in at 4%.
Moody's earns the No. 2 rank among its peers in the Commercial Services-Market Research industry group. S&P Global is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
